Insurer, Insured Costs for HIV PrEP Rising in the United States

WEDNESDAY, Sept. 9, 2020 -- From 2014 to 2018, there were increases noted in third-party and out-of-pocket (OOP) payments per 30 tenofovir disoproxil fumarate with emtricitabine (TDF-FTC) tablets for HIV preexposure prophylaxis (PrEP), according to...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news